{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-034837","form_type":"8-K","ticker":"CODX","cik":"0001692415","company_name":"Co-Diagnostics, Inc.","filed_at":"2026-07-27T21:05:36+00:00","discovered_at":"2026-07-27T21:08:00.268928+00:00","generated_at":"2026-07-27T21:08:27.324128+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Co-Diagnostics removes $10M cap on ATM equity offering with Maxim Group","bullets":["Amendment to equity distribution agreement removes fixed $10M aggregate limit on common stock sales.","Future sales limited only by registered shares available under effective S-3 registration statement.","Company extends standstill period with prior investors to August 14, 2026, restricting further equity issuances.","Sales will be made through Maxim Group as agent under new prospectus supplement filed July 27, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-034837","json":"https://secwatch.observer/filing/0001493152-26-034837.json","markdown":"https://secwatch.observer/filing/0001493152-26-034837.md","text":"https://secwatch.observer/filing/0001493152-26-034837.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1692415/000149315226034837/0001493152-26-034837-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1692415/000149315226034837/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-27T21:08:27.324128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}